Ketamine Hydrochloride 65219-0184
Product NDC
65219-0184- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 10, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215808
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ketamine Hydrochloride | 10 mg/mL |
Drug Class
General Anesthesia [PE]General Anesthetic [EPC]
Packaging Options(1)
10 VIAL in 1 TRAY (65219-184-20) / 20 mL in 1 VIAL (65219-184-01)